168 related articles for article (PubMed ID: 23274396)
21. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.
Elias D; Benizri E; Di Pietrantonio D; Menegon P; Malka D; Raynard B
Ann Surg Oncol; 2007 Feb; 14(2):509-14. PubMed ID: 17096054
[TBL] [Abstract][Full Text] [Related]
22. Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model.
Piché N; Leblond FA; Sidéris L; Pichette V; Drolet P; Fortier LP; Mitchell A; Dubé P
Ann Surg; 2011 Jul; 254(1):138-44. PubMed ID: 21494122
[TBL] [Abstract][Full Text] [Related]
23. Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode.
Hribaschek A; Meyer F; Ridwelski K; Kuester D; Lippert H
Eur Surg Res; 2010; 44(2):74-81. PubMed ID: 20051689
[TBL] [Abstract][Full Text] [Related]
24. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of cisplatin in semi-closed hyperthermic peritoneal perfusion (HPP) for treatment of peritoneal carcinomatosis.
Cattel L; De Simone M; Passera R; Verlengo MC; Delprino L
Anticancer Res; 2004; 24(3b):2041-5. PubMed ID: 15274398
[TBL] [Abstract][Full Text] [Related]
26. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics.
de Lima Vazquez V; Stuart OA; Mohamed F; Sugarbaker PH
Cancer Chemother Pharmacol; 2003 Aug; 52(2):108-12. PubMed ID: 12759776
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: initial experience in Oaxaca, Mexico.
García-Matus R; Hernández-Hernández CA; Leyva-García O; Vásquez-Ciriaco S; Flores-Ayala G; Navarro-Hernández Q; Pérez-Bustamante G; Valencia-Mijares NM; Esquivel J
Am Surg; 2012 Sep; 78(9):942-6. PubMed ID: 22964201
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunction.
Baur M; Drescher A; Gneist M; Dittrich C; Jaehde U
Cancer Chemother Pharmacol; 2008 Jan; 61(1):97-104. PubMed ID: 17396265
[TBL] [Abstract][Full Text] [Related]
29. Initial experience with hyperthermic intraperitoneal chemotherapy.
Turrini O; Lambaudie E; Faucher M; Viret F; Blache JL; Houvenaeghel G; Delpero JR
Arch Surg; 2012 Oct; 147(10):919-23. PubMed ID: 23117830
[TBL] [Abstract][Full Text] [Related]
30. [Prospective study of quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using oxaliplatin for peritoneal carcinomatosis].
Lim C; Tordjmann D; Gornet JM; Nemeth J; Valleur P; Pocard M
Bull Cancer; 2010 Sep; 97(9):1053-60. PubMed ID: 20693116
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study.
Gesson-Paute A; Ferron G; Thomas F; de Lara EC; Chatelut E; Querleu D
Ann Surg Oncol; 2008 Jan; 15(1):339-44. PubMed ID: 17943387
[TBL] [Abstract][Full Text] [Related]
32. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance.
Elias D; Matsuhisa T; Sideris L; Liberale G; Drouard-Troalen L; Raynard B; Pocard M; Puizillou JM; Billard V; Bourget P; Ducreux M
Ann Oncol; 2004 Oct; 15(10):1558-65. PubMed ID: 15367418
[TBL] [Abstract][Full Text] [Related]
33. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
[TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetics of oxaliplatin.
Delord JP; Umlil A; Guimbaud R; Grégoire N; Lafont T; Canal P; Bugat R; Chatelut E
Cancer Chemother Pharmacol; 2003 Feb; 51(2):127-31. PubMed ID: 12647013
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis.
Cashin PH; Ehrsson H; Wallin I; Nygren P; Mahteme H
Eur J Clin Pharmacol; 2013 Mar; 69(3):533-40. PubMed ID: 22983312
[TBL] [Abstract][Full Text] [Related]
36. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
Cashin PH; Graf W; Nygren P; Mahteme H
Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
[TBL] [Abstract][Full Text] [Related]
37. Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis.
Sugarbaker PH; Van der Speeten K; Anthony Stuart O; Chang D
Eur J Surg Oncol; 2011 Aug; 37(8):719-26. PubMed ID: 21621952
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
[TBL] [Abstract][Full Text] [Related]
39. Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments.
Roviello F; Caruso S; Marrelli D; Pedrazzani C; Neri A; De Stefano A; Pinto E
Surg Oncol; 2011 Mar; 20(1):e38-54. PubMed ID: 20888755
[TBL] [Abstract][Full Text] [Related]
40. Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients.
Msika S; Gruden E; Sarnacki S; Orbach D; Philippe-Chomette P; Castel B; Sabaté JM; Flamant Y; Kianmanesh R
J Pediatr Surg; 2010 Aug; 45(8):1617-21. PubMed ID: 20713209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]